BRCA2 and endometrial cancer: This study, therefore, sought to determine whether BRCA pathogenic variants are associated with an increased risk of endometrial cancer compared with the general population using a large, well-described cohort of BRCA1 and BRCA2 pathogenic variant carriers with prospective follow-ups.